Lyndsay Harris, MD (IMAGE) ECOG-ACRIN Cancer Research Group Caption 'Overall, the NCI-MATCH trial is providing insight into tumor types that might benefit from targeted therapies.' Credit National Cancer Institute Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.